Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: Studies in insulin-resistant and insulin-sensitized Syrian golden hamsters

Endocrinology

Volumn 145, Issue 11, 2004, Pages 5006-5012

  Lewis, Gary F ^a,b   Naples, Mark ^a   Uffelman, Kristine ^a   Leung, Nathalie ^a   Szeto, Linda ^a   Adeli, Khosrow ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B48; FATTY ACID; FRUCTOSE; GLYCEROL; HEPARIN; INSULIN; INTRALIPID; LIPOPROTEIN; OLEIC ACID; ROSIGLITAZONE; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; EX VIVO STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; HAMSTER; IN VIVO STUDY; INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE; INTESTINE CELL; LIPOPROTEIN SYNTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; ANTICOAGULANTS; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; BLOOD GLUCOSE; CELLS, CULTURED; CRICETINAE; DETERGENTS; ENTEROCYTES; FASTING; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; HEPARIN; INSULIN; INSULIN RESISTANCE; INTESTINES; MALE; MESOCRICETUS; POLYETHYLENE GLYCOLS; TRIGLYCERIDES;

EID: 9244233804     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1559     Document Type: Article

References (47)

1. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H 1999 Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99:2858-2860
2. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsumura T, Ohta Y, Nakano T, Nakajima K, Yasue H 1998 Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 137:341-349
3. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, Schaefer EJ 2001 Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154:229-236
4. Mero N, Malmstrom R, Steiner G, Taskinen MR, Syvanne M 2000 Post-prandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 150:167-177
5. Karpe F, Boquist S, Tang R, Bond GM, de Faire U, Hamsten A 2001 Remnant lipoproteins are related to ultima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res 42:17-21
6. Cohn JS 1998 Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol 14(Suppl B):18B-27B
7. Lewis GF, Carpentier A, Adeli K, Giacca A 2002 Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229
8. Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF 2001 Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11:170-176
9. Lewis GF 1997 Fatty acid regulation of very low density lipoprotein (VLDL) production. Curr Opin Lipidol 8:146-153
10. Zhang YL, Hernandez-Ono A, Ko C, Yasunaga K, Huang LS, Ginsberg HN 2004 Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J Biol Chem 279:19362-19374
11. Dashti N, Wolfbauer G 1987 Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 28:423-436
12. Cianflone KM, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD 1990 Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res 31:2045-2055
13. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J 1989 The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065-1077
14. Byrne CD, Brindle NP, Wang TW, Hales CN 1991 Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J 280:99-104
15. Byrne CD, Wang TW, Hales CN 1992 Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J 288:101-107
16. Dixon JL, Furukawa S, Ginsberg HN 1991 Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 266:5080-5086
17. White AL, Graham DL, LeGros J, Pease RJ, Scott J 1992 Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J Biol Chem 267:15657-15664
18. Gibbons GF, Bartlett SM, Sparks CE, Sparks JD 1992 Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J 287:749-753
19. Levinson M, Oswald B, Quarfordt S 1990 Serum factors influencing cultured hepatocyte exogenous and endogenous triglyceride. Am J Physiol 259: G15-G20
20. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G 1995 Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166
21. Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, Adeli K 2002 Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogeneeis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277:31646-31655
22. Zoltowska M, Ziv E, Delvin E, Sinnett D, Kalman R, Garofalo C, Seidman E, Levy E 2003 Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52:2539-2545
23. Curtin A, Deegan P, Owens O, Colling P, Johnson A, Tomkin GH 1996 Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetol 33:205-210
24. Gleeson A, Anderton K, Owens O, Bennett A, Collins P, Johnson A, White D, Tomkin GH 1999 The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42:944-948
25. Phillips C, Owens D, Collins P, Tomkin GH 2002 Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly? Atherosclerosis 160:355-360
26. Glazer NB, Cheatham WW 2001 A comprehensive review of the antidiabetic agent rosiglitazone. Clin Ther 23:307-308
27. Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE 1992 Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res 33:843-851
28. Liu GL, Fan LM, Redinger RN 1991 The association of hepatic apoprotein and lipid metabolism in hamsters and rats. Comp Biochem Physiol A 99:223-228
29. Taghibiglou C, Rudy D, Van Iderstine SC, Aiton A, Cavallo D, Cheung R, Adeli K 2000 Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. J Lipid Res 41:499-513
30. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K 2000 Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular apob degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275:8416-8425
31. Leung N, Naples M, Uffelman K, Szeto L, Adeli K, Lewis GF 2004 Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance. Atherosclerosis 174:235-241
32. Karpe F, Hamsten A, Uffelman K, Steiner G 1996 Apolipoprotein B48 Methods Enzymol 263:95-104
33. Perreault N, Beaulieu JF 1998 Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res 245:34-42
34. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
35. Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF 2002 Ameliorate hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795-28802
36. Deleted in proof
37. Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi SE, Shulman GI, Petersen KF 2002 The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes 51:797-802
38. Miles JM, Wooldridge D, Grellner WJ, Windsor S, Isley WL, Klein S, Harris WS 2003 Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52:675-681
39. Levy E 1992 The 1991 Borden Award Lecture. Selected aspects of intraluminal and intracellular phases of intestinal fat absorption. Can J Physiol Pharmacol 70:413-419
40. Lehner R, Kuksis A 1995 Triacylglycerol synthesis by purified triacylglycerol synthetase of rat intestinal mucosa. Role of acyl-CoA acyltransferase. J Biol Chem 270:13630-13636
41. Mansbach CM, Nevin P 1998 Intracellular movement of triacylglycerols in the intestine. J Lipid Res 39:963-968
42. Nutting DF, Kumar NS, St Hilaire RJ, Mansbach CM 1999 Nutrient absorption. Curr Opin Clin Nutr Metab Care 2:413-419
43. Glickman RM, Kilgore A, Khorana J 1978 Chylomicron apoprotein localization within rat intestinal epithelium: studies of normal and impaired lipid absorption. J Lipid Res 19:260-268
44. Glickman RM, Khorana J, Kilgore A 1976 Localization of apolipoprotein B in intestinal epithelial cells. Science 193:1254-1255
45. Glickman RM, Kirsch K 1973 Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron appproteins. J Clin Invest 52:2910-2920
46. Renner F, Schemthaner G, Gangl A 1984 Intestinal metabolism of plasma free fatty acids in streptozotocin diabetic rats. Lipids 19:875-879
47. Gangl A, Ockner RK 1975 Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control. J Clin Invest 55:803-813